[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100364856":3},{"organization":4,"armGroups":7,"interventions":15,"overallOfficials":27,"centralContacts":34,"locations":43,"responsibleParty":82,"collaborators":21,"id":84,"slug":85,"hasResults":86,"nctId":87,"briefTitle":88,"officialTitle":89,"acronym":90,"eligibilityCriteria":91,"healthyVolunteers":86,"sex":92,"minAge":93,"maxAge":21,"enrollmentInfo":94,"targetDuration":21,"studyType":97,"phases":98,"briefSummary":100,"conditions":101,"keywords":103,"overallStatus":46,"whyStopped":21,"lastUpdateSubmitDate":110,"lastUpdatePostDateStruct":111,"startDateStruct":114,"completionDateStruct":116,"leadSponsor":118,"locationsCount":119},{"fullName":5,"class":6},"Centre Hospitalier Universitaire de Saint Etienne","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"QuantiFERON Test","EXPERIMENTAL","Patient with CytoMegaloVirus (CMV) infection will be included. They will have biopsies and blood samples, composite of QuantiFERON-CytoMegaloVirus (QF-CMV) assay.",[13,14],"Procedure: Biopsies","Biological: Blood samples",[16,22],{"type":17,"name":18,"description":19,"armGroupLabels":20,"otherNames":21},"PROCEDURE","Biopsies","Two more biopsies in inflammatory zone will be collected.",[9],null,{"type":23,"name":24,"description":25,"armGroupLabels":26,"otherNames":21},"BIOLOGICAL","Blood samples","Blood samples will be performed necessary at QuantiFERON-CMV (QF-CMV) test.",[9],[28,31],{"name":29,"affiliation":5,"role":30},"Xavier ROBLIN, MD PhD","PRINCIPAL_INVESTIGATOR",{"name":32,"affiliation":5,"role":33},"Sylvie PILLET, PhD","STUDY_DIRECTOR",[35,40],{"name":29,"role":36,"phone":37,"phoneExt":38,"email":39},"CONTACT","(0)477828119","+33","xavier.roblin@chu-st-etienne.fr",{"name":32,"role":36,"phone":41,"phoneExt":38,"email":42},"(0)477828315","sylvie.pillet@chu-st-etienne.fr",[44,68],{"facility":45,"status":46,"city":47,"state":21,"zip":21,"country":48,"countryCode":49,"cosmosGeoPoint":50,"geoPoint":55,"contacts":56},"HCL-Hôpital Lyon Sud","RECRUITING","Lyon","France","FR",{"type":51,"coordinates":52},"Point",[53,54],4.84789,45.74906,{"lat":54,"lon":53},[57,59,62,64,66],{"name":58,"role":30,"phone":21,"phoneExt":21,"email":21},"Stéphane NANCEY, MD PhD",{"name":60,"role":61,"phone":21,"phoneExt":21,"email":21},"Gilles BOSCHETTI, MD PhD","SUB_INVESTIGATOR",{"name":63,"role":61,"phone":21,"phoneExt":21,"email":21},"Claire GAY, MD",{"name":65,"role":61,"phone":21,"phoneExt":21,"email":21},"Bernard FLOURIE, MD",{"name":67,"role":61,"phone":21,"phoneExt":21,"email":21},"Pauline DANION, MD",{"facility":69,"status":46,"city":70,"state":21,"zip":21,"country":48,"countryCode":49,"cosmosGeoPoint":71,"geoPoint":75,"contacts":76},"Chu Saint-Etienne","Saint-Etienne",{"type":51,"coordinates":72},[73,74],4.39,45.43389,{"lat":74,"lon":73},[77,78,80],{"name":29,"role":30,"phone":21,"phoneExt":21,"email":21},{"name":79,"role":61,"phone":21,"phoneExt":21,"email":21},"Pauline VEYRARD, MD",{"name":81,"role":61,"phone":21,"phoneExt":21,"email":21},"Emilie DEL TEDESCO, MD",{"type":83,"investigatorFullName":21,"investigatorTitle":21,"investigatorAffiliation":21,"oldNameTitle":21,"oldOrganization":21},"SPONSOR","100364856","quantiferon-cmv-test-in-a-prediction-for-colic-cytomegalovirus-reactivation-during-ulcerative-colitis-100364856",false,"NCT04030676","QuantiFERON-CMV Test in a Prediction for Colic Cytomegalovirus Reactivation During Ulcerative Colitis","Place of the QuantiFERON-CMV (QF-CMV) Test in a Prediction for Colic Cytomegalovirus Reactivation During Ulcerative Colitis (UC)","RECOHFERRON","Inclusion Criteria:\n\n* Patient with seropositive for CytoMegaloVirus (CMV) (IgG+)\n* Patient requiring hospitalization for flare of Ulcerative Colitis (UC) with Mayo score \\> 5 and an endoscopic subscore ≥ 2\n* Social security affiliation\n* Signed informed consent\n\nExclusion Criteria:\n\n* Wardship patient and curatorial patient\n* Patient unable to understand or sign the protocol\n* Colectomy total or partial","ALL","18 Years",{"count":95,"type":96},196,"ESTIMATED","INTERVENTIONAL",[99],"NA","CytoMegaloVirus (CMV) infection impairs evolution of Ulcerative Colitis (UC) leading to more severe and resistant to immunosuppressive therapies flare-up. CytoMegaloVirus (CMV) reactivation is assessed by the quantification of the CytoMegaloVirus (CMV) DeoxyriboNucleic Acid (DNA) load by real-time PCR (qPCR) in colonic biopsies; this assay is invasive and costly. The QuantiFERON-CytoMegaloVirus (QF-CMV) assay measures the immune response against CytoMegaloVirus (CMV) in a blood specimen.",[102],"Cytomegalovirus Infections",[104,105,106,107,108,109],"Immune response against","QuantiFERON-CytoMegaloVirus (QF-CMV)","Ulcerative Colitis (UC)","CytoMegaloVirus (CMV)","quantitative PolymeraseChainReaction (qPCR)","ImmunoHistoChemistry (IHC)","2025-04-28",{"date":112,"type":113},"2025-04-29","ACTUAL",{"date":115,"type":113},"2019-07-17",{"date":117,"type":96},"2026-04",{"name":5,"class":6},2]